Literature DB >> 11885163

Smoking cessation programs for adolescents.

K A Donovan1.   

Abstract

Many smoking cessation programs for adult smokers are described in the medical and nursing literature. Programs designed to prevent smoking among adolescents and children also are prevalent in the literature. Despite these prevention programs, many adolescents choose to start smoking. Once adolescents begin smoking, it is difficult to find ways to help them quit. Few programs exist that are targeted to help this population with smoking cessation. This article provides an in-depth review of 5 smoking cessation programs designed for adolescents. Each of the programs presents unique strategies for helping teenage smokers quit. Techniques used in these programs include peer leadership, nicotine patch therapy, peer support, computer instruction, and one-on-one counseling with a nurse practitioner. Each program was studied for efficacy with adolescents. Although none of the programs reviewed showed remarkable success, they serve as guides for future program development. Additional programs need to be developed and studied with larger, more diverse populations. Nurses must identify or develop smoking cessation programs that meet the needs of all types of adolescents and are effective in helping them to quit. Once designed, these smoking cessation programs should be made accessible to adolescents in a variety of settings.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11885163

Source DB:  PubMed          Journal:  J Sch Nurs        ISSN: 1059-8405            Impact factor:   2.835


  2 in total

Review 1.  [Interdisciplinary strategies versus doping].

Authors:  Karin Vitzthum; Stefanie Mache; David Quarcoo; David A Groneberg; Norman Schöffel
Journal:  Wien Klin Wochenschr       Date:  2010-06       Impact factor: 1.704

Review 2.  Adolescent smoking: epidemiology and approaches for achieving cessation.

Authors:  Alexander V Prokhorov; Karen Suchanek Hudmon; Nancy Stancic
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.